News

Dr. James O’Keefe, a co-investigator of this study, explains why GLP-1 medications may be uniquely effective in addressing addictive behaviors like recreational drug use, alcohol consumption, and food cravings.

This week we're talking with Dr. Sanjaya Gupta, cardiologist at Saint Luke’s Mid America Heart Institute, about the latest treatment options for this underdiagnosed heart condition.

Winter’s sting is in full effect, with evening temperatures in our metro dropping near zero again Thursday night. Here's how you can protect yourself from cold weather injuries.

Todd Shannon expresses thanks to Saint Luke's providers for their life-saving interventions which ultimately saved his life.

Art Still has ATTR amyloidosis, an inherited heart condition that dramatically impacts Black men and the former Kansas City Chiefs defensive end wants to raise awareness.

Saint Luke's is spreading awareness, love, and humor this season with a series of heartfelt valentine messages, reminding people to take care of their own hearts.

Growing research shows why popular GLP-1 weight loss medications might be beneficial for people with multiple sclerosis, but the jury’s still out.

"Jill asked, 'If this was your father where would you take him?' And [the doctor] said, 'Saint Luke’s in Kansas City.' And Saint Luke’s saved my life."

Dr. Adnan Chhatriwalla, interventional cardiologist at Saint Luke’s Mid America Heart Institute, talks about symptoms of heart valve disease, treatment, and keys to long-term heart health.

Understanding how mental health conditions like depression, anxiety, and chronic stress affect cardiovascular health in older adults is crucial for promoting holistic care and improving quality of life in this population.